N
Nithima Sumpradit
Researcher at Food and Drug Administration
Publications - 18
Citations - 3682
Nithima Sumpradit is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Medical prescription & Direct-to-consumer advertising. The author has an hindex of 9, co-authored 16 publications receiving 2891 citations. Previous affiliations of Nithima Sumpradit include Thailand Ministry of Public Health & University of Michigan.
Papers
More filters
Journal ArticleDOI
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan,Ramanan Laxminarayan,Ramanan Laxminarayan,Adriano Duse,Chand Wattal,Anita K. M. Zaidi,Heiman F. L. Wertheim,Nithima Sumpradit,Erika Vlieghe,Gabriel Levy Hara,Ian M. Gould,Herman Goossens,Christina Greko,Anthony D. So,Maryam Bigdeli,Goeran Tomson,Will Woodhouse,Eva Ombaka,Arturo Quizhpe Peralta,Farah Naz Qamar,Fatima Mir,Sam Kariuki,Zulfigar A. Bhutta,Anthony R.M. Coates,Richard Bergstrom,Gerard D. Wright,Eric D. Brown,Otto Cars +27 more
TL;DR: The global situation of antibiotic resistance, its major causes and consequences, and key areas in which action is urgently needed are described and identified.
Journal ArticleDOI
Antibiotic development — economic, regulatory and societal challenges
Christine Årdal,Manica Balasegaram,Ramanan Laxminarayan,David McAdams,Kevin Outterson,John H. Rex,Nithima Sumpradit +6 more
TL;DR: The challenges that are contributing to the decline in antibiotic drug discovery and development, and the international and national initiatives aimed at incentivizing research and the development of new antibiotics to improve the economic feasibility of antibiotic development are discussed.
Journal ArticleDOI
Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand
Nithima Sumpradit,Pisonthi Chongtrakul,Kunyada Anuwong,Somying Pumtong,Kedsenee Kongsomboon,Parichart Butdeemee,Jurairat Khonglormyati,Santi Chomyong,Parnuchote Tongyoung,Suraphol Losiriwat,Piyanooch Seesuk,Pongthep Suwanwaree,Viroj Tangcharoensathien +12 more
TL;DR: ASU is clearly a workable entry point for efforts to rationalize the use of medicines in Thailand, and its long-term sustainability will require continued local commitment and political support, effective auditing and integration of ASU into routine systems with appropriate financial incentives.
Journal ArticleDOI
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar : an open-label, randomised, controlled trial
Thomas Althaus,Thomas Althaus,Rachel C Greer,Rachel C Greer,Myo Maung Maung Swe,Joshua Cohen,Ni Ni Tun,James Heaton,Supalert Nedsuwan,Daranee Intralawan,Nithima Sumpradit,Sabine Dittrich,Zoë Doran,Naomi Waithira,Naomi Waithira,Hlaing Myat Thu,Han Win,Janjira Thaipadungpanit,Prapaporn Srilohasin,Mavuto Mukaka,Mavuto Mukaka,Pieter W Smit,Ern Charoenboon,Marco Johannes Haenssgen,Marco Johannes Haenssgen,Tri Wangrangsimakul,Tri Wangrangsimakul,Stuart D. Blacksell,Stuart D. Blacksell,Direk Limmathurotsakul,Direk Limmathurotsakul,Nicholas P. J. Day,Nicholas P. J. Day,Frank Smithuis,Yoel Lubell,Yoel Lubell +35 more
TL;DR: In febrile patients attending primary care, testing for CRP at point of care with a threshold of 40 mg/L resulted in a modest but significant reduction in antibiotic prescribing, with patients with high CRP being more likely to be prescribed an antibiotic.
Journal ArticleDOI
New chapter in tackling antimicrobial resistance in Thailand
Nithima Sumpradit,Suriya Wongkongkathep,Sitanan Poonpolsup,Noppavan Janejai,Wantana Paveenkittiporn,Phairam Boonyarit,Sasi Jaroenpoj,Niyada Kiatying-Angsulee,Wantanee Kalpravidh,Angkana Sommanustweechai,Viroj Tangcharoensathien +10 more
TL;DR: The experience of Thailand in developing its national strategic plan on antimicrobial resistance and the need for sustained political commitment and multisectoral collaboration are described.